Nuragab M Tablet is a combination medication containing Gabapentin 300 mg and Methylcobalamin 500 mcg, formulated to manage neuropathic pain and support nerve health. Gabapentin, an anticonvulsant, modulates neuronal excitability by inhibiting voltage-gated calcium channels, thereby reducing abnormal nerve activity associated with neuropathic pain conditions such as diabetic neuropathy, postherpetic neuralgia, and peripheral neuropathy. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and myelin sheath repair, enhancing nerve conduction and promoting recovery in neuropathic disorders. The synergistic effect of Gabapentin and Methylcobalamin in Nuragab M Tablet provides effective pain relief while supporting nerve repair mechanisms. It is indicated for the treatment of neuropathic pain, diabetic neuropathy, and other peripheral nerve disorders. Nuragab M should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Common side effects may include dizziness, somnolence, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, and abrupt discontinuation should be avoided to prevent withdrawal symptoms. Nuragab M Tablet offers a comprehensive approach to neuropathic pain management by combining symptomatic relief with neurotrophic support.